Oxygen—The Forgotten Drug: The Importance of Proper Dosing
Presented by Patrick J. Dunne, MEd, RRT, FAARC
The clinical value of properly prescribed long-term oxygen therapy (LTOT) has been well established for COPD patients afflicted with severe chronic arterial hypoxemia. Proven benefits include improved survival, increased exercise tolerance and enhanced quality of life. Low flow supplemental oxygen therapy is no different than any other controller medication prescribed for respiratory-related symptoms such as bronchoconstriction or airway inflammation. Like other respiratory medications, LTOT must be properly prescribed and dosed for optimum clinical and economic benefits.
View the Webcast
This webcast is available for streaming over the Internet. You will need to have the free Flash Player installed.
Download the Webcast
This webcast is also available for downloading in a mobile-optimized format.
Register for the Test
To receive CRCE credit after viewing this webcast, you will need to register and pay for access to the accompanying test ($7.50 for members, $15 for non-members). Once registered, you will receive an email confirmation with full instructions. You will not be granted access to the test unless you have registered.
Take the Test
After registering, you will have online access to this webcast’s accompanying test at the AARC’s Examination Central.
Please check the Help Page for tutorials and frequently asked questions.